Benson J, Tschachler E, Gessain A, Yanagihara R, Gallo R C, Franchini G
Laboratory of Tumor Cell Biology, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20892.
AIDS Res Hum Retroviruses. 1994 Jan;10(1):91-6. doi: 10.1089/aid.1994.10.91.
The so-called cosmopolitan strains of human T cell leukemia/lymphotropic virus type I (HTLV-I) from Japan, Africa, the West Indies, and the Americas differ only slightly (< 3%) in their genomic sequence. On the other hand, the Melanesian strains of HTLV-I are somewhat more divergent, exhibiting only 93% sequence similarity with the cosmopolitan strains. Despite this difference, sera from individuals infected with Melanesian strains cross-react with T cells infected with cosmopolitan strains of HTLV-I, indicating an overall conservation of the B cell immunoprevalent epitopes. Neutralizing antibodies against HTLV-I in sera from virus-infected Africans and Melanesians were assayed by determining their ability to block the formation of syncytia in cocultures of 8166 and T cell lines harboring either cosmopolitan or Melanesian HTLV-I isolates. All six African sera blocked the formation of syncytia with cells infected with HTLV-IC91-PL, a viral isolate from the United States. Similarly, all six Melanesian sera inhibited syncytium formation with cells infected with HTLV-IMEL3, a virus isolate from the Solomon Islands. Although most of these sera inhibited syncytium formation in cell cultures carrying the cosmopolitan as well as the Melanesian HTLV-I strains, neutralizing antibody titers tended to be higher against the homologous virus. All sera failed to inhibit syncytium formation when cells were infected with HTLV-II. These data indicate the involvement of one or more epitopes in syncytial formation, some of which are conserved in all strains of HTLV-I.(ABSTRACT TRUNCATED AT 250 WORDS)
来自日本、非洲、西印度群岛和美洲的所谓人类T细胞白血病/淋巴瘤病毒I型(HTLV-I)的世界性毒株,其基因组序列仅存在轻微差异(<3%)。另一方面,HTLV-I的美拉尼西亚毒株差异稍大,与世界性毒株仅表现出93%的序列相似性。尽管存在这种差异,但感染美拉尼西亚毒株个体的血清与感染HTLV-I世界性毒株的T细胞发生交叉反应,表明B细胞免疫优势表位总体上是保守的。通过测定病毒感染的非洲人和美拉尼西亚人血清中中和抗体阻断8166细胞与携带世界性或美拉尼西亚HTLV-I分离株的T细胞系共培养中合胞体形成的能力,对其进行了检测。所有六份非洲血清均阻断了与感染HTLV-IC91-PL(一种来自美国的病毒分离株)的细胞形成合胞体。同样,所有六份美拉尼西亚血清均抑制了与感染HTLV-IMEL3(一种来自所罗门群岛的病毒分离株)的细胞形成合胞体。尽管这些血清中的大多数在携带世界性以及美拉尼西亚HTLV-I毒株的细胞培养物中抑制了合胞体形成,但针对同源病毒时中和抗体滴度往往更高。当细胞感染HTLV-II时,所有血清均未能抑制合胞体形成。这些数据表明一个或多个表位参与了合胞体形成,其中一些表位在所有HTLV-I毒株中都是保守的。(摘要截选至250字)